Espoo, Finland, 6 December 2019 – HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, announces that data on its transcatheter mitral valve will be presented at the ICI Meeting in Tel Aviv, Israel, 8-10 December 2019.
Clinical advisor to HVR Cardio, Kari Kervinen, MD, PhD, from Oulu University Hospital, Finland, will present the data in a talk titled: HVR Cardio Transcatheter Mitral Valve Repair; Physiological Downsizing of the Mitral Annulus.
The ICI Meeting is an acclaimed forum which aims to explore, fuel, spark, and be involved in the innovations that will shape the future of cardiovascular systems and beyond. ICI’s dynamic environment has contributed to this process by facilitating global interaction between physicians, entrepreneurs, academia and industry and by building bridges leading to innovation.